SOURCE: iiBIG

iiBIG

September 28, 2010 10:44 ET

Pharma Sales & Marketing New Market Trends and Strategies Covered at iiBIG's Baltimore Forum in November

NEW YORK, NY--(Marketwire - September 28, 2010) -  iiBIG presents the Next Generation Pharma Sales & Marketing Summit, scheduled for November 16-17, 2010 at the Baltimore Marriott Inner Harbor at Camden Yards in Baltimore, MD. The pharmaceutical sales and marketing landscape has changed dramatically over the past few years with an expectation of global sales of pharmaceuticals to grow at a rate of 5%-8% annually over the next five years. At the center of this highly regulated industry emerges an increase of communications, digital marketing efforts, social media and sales force success strategies. Today's pharmaceutical executives continue to create and implement influential campaigns with the goal of ultimately improving health outcomes by exploring new and dynamic selling techniques. At the same time, pharmaceutical sales representatives face increasing difficulty due to falling physician accessibility, stronger regulation in the industry, and changing operational models surrounding healthcare delivery.

This event will address the value of both sales and marketing operations within large, mid-size, and specialty pharmaceutical companies. It will feature keynote presentations from industry leaders, panel debates, relevant case studies, and high-level networking. This is an essential opportunity for any executive striving to make the most out of cutting-edge and alternative sales and marketing innovation best-practices.

The executive speaking faculty includes: A.T. Kearney; Acorda Therapeutics; Amarin Corporation; Astellas Pharma; AstraZeneca; Baxter; Biomet Microfixation; Bristol-Myers Squibb; comScore, Inc.; Covidien; Daiichi Sankyo, Inc.; Digitas Health; Epocrates; Genentech; Genzyme Genetics; GSW Worldwide; Harris Interactive; HighPoint Solutions; King Pharmaceuticals; Klick Pharma; Lundbeck Inc.; M2 Worldwide; MedImmune; NicOx; NuPathe; OSI Pharmaceuticals; Pacific Bridge Medical ; Pfizer; Physicians Interactive; PricewaterhouseCoopers ; Saint Joseph's University; Sequella; Shire Pharmaceuticals; SymCare Personalized Health Solutions, Inc. (a Johnson & Johnson Company); Symphogen, Inc.; Teva Pharmaceuticals; UCB, Inc.; and WellDoc Communications, Inc.

For conference details: http://www.iibig.com/P1005

ABOUT iiBIG
iiBIG (International Institute for Business Information & Growth) is an unbiased, independent company dedicated to organizing business-to-business conferences and seminars for senior-level business executives. We provide learning and networking settings for some of the business community's BIGgest thinkers - those who occupy the highest levels in their companies and organizations. Our events focus on the most pressing and timely issues facing decision-makers in today's global economy. For more information, visit: http://www.iibig.com.

Contact Information